Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04246177 |
|---|---|
| Brief Title: | Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012) |
| First Submitted : | January 27, 2020 |
| First Submitted that Met QC Criteria : | January 27, 2020 |
| First Posted : | January 29, 2020 |
| Last Update Submitted that Met QC Criteria : | January 31, 2023 |
| Last Update Posted : | February 2, 2023 |